Georgia Regents University Cancer Clinical Research Unit — Augusta, Georgia

Georgia Regents University Cancer Clinical Research Unit is a clinical research site located in Augusta, Georgia, United States 30912.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Georgia Regents University Cancer Clinical Research Unit has participated in 2 clinical trials.

Therapeutic areas: Classical Hodgkin's Lymphoma, Metastatic Melanoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgia Regents University Cancer Clinical Research Unit?

Georgia Regents University Cancer Clinical Research Unit has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgia Regents University Cancer Clinical Research Unit conducted?

Georgia Regents University Cancer Clinical Research Unit has 2 clinical trials on record. Their work covers Classical Hodgkin's Lymphoma, Metastatic Melanoma.

Is Georgia Regents University Cancer Clinical Research Unit accredited by Crixeo Health?

Georgia Regents University Cancer Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgia Regents University Cancer Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.